According to AVAC, “in the near-term, a DPP could increase the uptake of PrEP (pre-exposure prophylaxis drugs) — decreasing new HIV infections among women in high-burden settings — and reduce the number of unintended pregnancies. A DPP could also lay the groundwork for the development and rollout of other MPTs currently in the research pipeline, such as vaginal rings, injectables, implants and films.”
The acceptability study in South Africa compares adherence, acceptability and preference between the DPP vs. two separate pills.
Catalyst Global is also co-leading a technical sub-group with AVAC to develop recommendations for provider counseling messages for the DPP. These recommendations will be foundational for communication by health care providers in countries where DPP goes to market.
United States Agency for International Development (USAID)
South Africa
DPP (an over-encapsulated product, containing both oral PrEP and an oral contraceptive)
2020-2023
“WCG Cares (now Catalyst Global) is a valued and committed partner on the Dual Prevention Pill (DPP) Consortium. They have brought their deep expertise on supporting contraceptive introduction to bear on the market preparation strategy for this new multi-purpose technology. They are reliable, assiduous, and able to strategically think through complex issues.”
Partners
Partners
Project Publications
Related posts
Contraceptive product introduction is complex. The Contraceptive Innovation Index, designed to facilitate discussions and decision-making around the introduction and scale up of contraceptive technologies, offers a comprehensive but streamlined way to organize and make sense of information.
Regulatory requirements for product registration can be overwhelming. They’re complex, vary by country, and frequently change. We know they’re important (safe medicines, yes!), but what does it actually take to get a product from the manufacturing plant onto the shelves in your local pharmacy? Let’s take a look together.
The Product Registration Toolkit is a digital collection of adaptable resources to guide the process of registering health products, like contraceptives, in low- and middle-income countries.